| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |